Anaptysbio, Inc
ANABNasdaqCIK 1370053HealthcareFiscal year ends Jun 30
Reports and events: 187 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2120:20 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-26-396690 |
| 2026-08-1120:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-344583 |
| 2026-07-3020:05 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-326097 |
| 2026-06-2920:05 ET | DEF 14A | Proxy statementPeriod 2026-06-29 | 0001193125-26-288408 |
| 2026-06-2220:05 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-277505 |
| 2026-05-2920:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-248326 |
| 2026-05-2120:10 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001193125-26-234419 |
| 2026-05-1220:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219515 |
| 2026-05-1220:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219500 |
| 2026-05-1120:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-216745 |
| 2026-04-2820:10 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-187044 |
| 2026-04-2420:17 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-26-177317 |
| 2026-04-2021:25 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164330 |
| 2026-03-2713:19 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-127783 |
| 2026-03-0321:23 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-088290 |
| 2026-03-0321:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-088239 |
| 2026-01-0922:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001370053-26-000002 |
| 2025-11-2621:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001370053-25-000103 |
| 2025-11-2114:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001370053-25-000097 |
| 2025-11-2114:00 ET | 8-K | 8.01 Other events | 0001370053-25-000096 |
| 2025-11-1014:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001370053-25-000091 |
| 2025-11-0421:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001370053-25-000089 |
| 2025-11-0421:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-25-000088 |
| 2025-10-1420:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001370053-25-000083 |
| 2025-09-2920:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001370053-25-000081 |
| 2025-08-0620:22 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001370053-25-000064 |
| 2025-08-0620:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-25-000063 |
| 2025-06-1720:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001370053-25-000055 |
| 2025-06-0321:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001370053-25-000052 |
| 2025-05-0520:19 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001370053-25-000046 |
| 2025-05-0520:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-25-000045 |
| 2025-04-2920:36 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001370053-25-000038 |
| 2025-03-2413:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001370053-25-000028 |
| 2025-02-2721:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001370053-25-000024 |
| 2025-02-2721:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-25-000023 |
| 2025-02-1922:10 ET | 8-K | 7.01 Regulation FD disclosure | 0001370053-25-000014 |
| 2025-02-1213:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001370053-25-000010 |
| 2025-02-0313:55 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure | 0001370053-25-000002 |
| 2024-12-1121:06 ET | 8-K | 8.01 Other events | 0001370053-24-000067 |
| 2024-11-0521:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001370053-24-000054 |
| 2024-11-0521:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-24-000053 |
| 2024-08-1616:07 ET | SC 13D/A | Ownership report, active investor, amended | 0000935836-24-000533 |
| 2024-08-1420:43 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-200684 |
| 2024-08-0520:22 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001370053-24-000041 |
| 2024-08-0520:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-24-000039 |
| 2024-06-1220:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001370053-24-000029 |
| 2024-05-0920:24 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001370053-24-000027 |
| 2024-05-0920:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001370053-24-000026 |
| 2024-04-2420:05 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001370053-24-000019 |
| 2024-03-1120:36 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001370053-24-000011 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.